APPENDIX IX
975
TABLE IX-1 (
co n tin u ed
)
Component
Present Reference
Interval
(Examples)
Present
Unit
Conversion
Factor
SI
Reference
Interval
SI Unit
Significant
Symbol
Digits
Suggested
Minimum
Increment
Lysolphosphatidyl choline
1-2
%
of total
0.01
0.01-0.02
1
O.XX
0.01
Phytanic acid (P)
Trace-0.3
mg/dL
32.00
<10
jUmol/L
XX
5 jUmol/L
(Human) placental lactogen
(S) (HPL)
>4.0 After 30 wk
gestation
jUg/mL
46.30
>180
nmol/L
XXO
10 nmol/L
Phorphobilinogen (U)
Porphyrins
0.0-2.0
mg/24 h
4.420
0-9.0
jltmol/d
X.X
0.5 jumol/d
coproporphyrin (U)
45-180
Mg/24h
1.527
68-276
nmol/d
XXX
2 nmol/d
protoporphyrin (Ere)
15-50
jUg/dL
0.0177
0.28-0.90
JUmol/L
x.xx
0.02 jltmol/L
uroporphyrin (U)
5-20
jHg/24 h
1.204
6-24
nmol/d
XX
2 nmol/d
Uroporphyrinogen synthetase
(Ere)
22^12
mmol/mL/h
0.2778
6.0-11.8
mmol/(L • s)
X.X
0.2 mmol/(L ■
s)
Potassium ion (S)
3.5-5.0
mEq/L
mg/dL
1.00
0.2558
3.5-5.0
mmol/L
mmol/L
X.X
X.X
0.1 mmol/L
0.1 mmol/L
Potassium ion (U) (diet
dependent)
Pregnanediol (U)
25-100
mEq/24 h
1.00
25-100
mmol/d
XX
1 mmol/d
normal
pregnancy
1.0-6.0
Depends on
gestation
mg/24 h
3.120
3.0-18.5
jumol/d
XX.X
0.5 jUmol/d
Pregnanetriol (U)
Primidone (P)—
0.5-2.0
mg/24 h
2.972
1.5-6.0
lUmol/d
xx.x
0.5 jumol/d
therapeutic
6.0-10.0
mg/L
4.582
25^16
jUmol/L
x x
1 jtffnol/L
toxic
Procainamide (P)—
>10.0
mg/L
4.582
>46
jUmol/L
XX
1 jtflnol/L
therapeutic
4.0-8.0
mg/L
4.249
17-34
jUmol/L
XX
1 jUmol/L
toxic
>12.0
mg/L
4.249
>50
jUmol/L
XX
1 jltmol/L
N-acetylprocainamide (P)—
therapeutic
Progesterone (P)
4.0-8.0
mg/L
3.606
14-29
jxmol/L
XX
1 jltmol/L
follicular phase
<2
ng/mL
3.180
<6
nmol/L
XX
2 nmol/L
luteal phase
Progesterone receptors (T)
2-20
ng/mL
3.180
6-64
nmol/L
XX
2 nmol/L
negative
0-3
fmol
progesterone
bound/mg
cytosol protein
1.00
0-3
fmol
progesterone
bound/mg
protein
XX
1 fmol/mg
protein
doubtful
4-10
fmol
progesterone
bound/mg
cytosol protein
1.00
4-10
fmol
progesterone
bound/mg
cytosol
protein
XX
1 fmol/mg
protein
positive
>10
fmol
progesterone
bound/mg
cytosol protein
1.00
>10
fmol
progesterone
bound/mg
cytosol
protein
XX
1 fmol/mg
protein
Prolactin (P)
<20
ng/mL
1.00
<20
jUg/L
XX
ljUg/L
Propoxyphene (P)—toxic
>2.0
mg/L
2.946
>5.9
jUmol/L
X.X
0.1 jUmol/L
Propranolol (P) (Inderal)—
therapeutic
50-200
ng/mL
3.856
190-770
nmol/L
1XXO
10 nmol/L
Protein, total (S)
6.0-8.0
g/dL
10.0
60-80
g/L
XX
1 g/L
Protein, total (Sf)
<40
mg/dL
0.01
<0.40
g/L
X.XX
0.01 g/L
Protein, total (U)
<150
mg/24 h
0.001
<0.15
g/d
x.x x
0.01 g/d
Protryptyline (P)
100-300
ng/mL
3.797
380-1140
nmol/L
XXO
10 nmol/L
Pyruvate (B) (as pyruvic
acid)
Quinidine (P)—
0.30-0.90
mg/dL
113.6
35-100
jUmol/L
XXX
1 jumol/L
therapeutic
1.5-3.0
mg/L
3.082
4.Ô-9.2
jUmol/L
X.X
0.1 jUmol/L
toxic
Renin (P)
>6.0
mg/L
3.082
>18.5
jrmol/L
X.X
0.1 jumol/L
normal sodium diet
l . l - A . l
ng/mL/h
0.2778
0.30-1.14
ng/(L • s)
X.XX
0.02 ng/(L • s)
restricted sodium diet
6.2-12.4
ng/mL/h
0.2778
1.72-3.44
ng/(L • s)
x.x x
0.02 ng/(L • s)
previous page 1008 Bhagavan Medical Biochemistry 2001 read online next page 1010 Bhagavan Medical Biochemistry 2001 read online Home Toggle text on/off